TabletCefpodoxime 200mg
Cefpodoxime Proxetil
Third-generation oral cephalosporin with broad-spectrum activity against respiratory and urinary pathogens. Manufactured by Lupin and Cipla as a widely exported oral antibiotic.
Strengths
100mg / 200mg
Packing
10 tablets/strip
Origin
India (WHO-GMP)
MOQ
100 units
Export Price
On Request
Availability
In Stock
Product Specifications
Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.
Related Products
TabletAzithromycin 500mg
Azithromycin
Azalide subclass macrolide antibiotic that achieves exceptionally high and sustained intracellular tissue concentrations — up to 100-fold higher than plasma levels — enabling short 3-day or 5-day treatment courses for respiratory, skin, and sexually transmitted bacterial infections. Its anti-inflammatory properties beyond direct bacteriostasis provide additional clinical benefit in community-acquired pneumonia. Cipla and Alkem Labs manufacture 250mg and 500mg tablets exported globally as a staple of primary care antibiotic formularies.
CapsuleAmoxicillin 500mg
Amoxicillin Trihydrate
Aminopenicillin with extended gram-positive and gram-negative bactericidal activity, offering superior oral bioavailability (~90%) compared to ampicillin and the convenience of twice- or thrice-daily dosing for common community infections of the respiratory tract, urinary tract, skin, and ear. It is also a key component of H. pylori triple-eradication therapy and is a WHO Essential Medicine available in both capsule and dispersible tablet forms. Cipla and GSK manufacture 250mg and 500mg capsules exported to primary care markets globally.
TabletAugmentin 625mg
Amoxicillin + Clavulanate
Fixed-dose combination of amoxicillin with clavulanic acid, a potent beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation and restores its activity against beta-lactamase-producing strains of Staphylococcus, Haemophilus, Moraxella, and Klebsiella commonly encountered in community and hospital settings. Widely prescribed for sinusitis, otitis media, lower respiratory infections, UTIs, animal bites, and dental abscesses resistant to amoxicillin alone. GSK and Cipla supply 625mg and 1g tablets exported as a primary care antibiotic staple worldwide.
Need bulk pricing for Cefpodoxime 200mg?
Send us your quantity requirements and destination country for a custom quotation.
Get Bulk Quote